Corcept Therapeutics
CORT
CORT
224 hedge funds and large institutions have $1.51B invested in Corcept Therapeutics in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 67 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
10% more funds holding
Funds holding: 204 → 224 (+20)
1.06% more ownership
Funds ownership: 77.13% → 78.19% (+1.1%)
9% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 67
Holders
224
Holding in Top 10
4
Calls
$12.4M
Puts
$10.8M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$10.4M | |
| 3 | +$6.24M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$6.22M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$5.16M |
Top Sellers
| 1 | -$7.16M | |
| 2 | -$6.8M | |
| 3 | -$6.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.91M |
| 5 |
Man Group
London,
United Kingdom
|
-$4.39M |